MoonLake Immunotherapeutics (MLTX) Enterprise Value (2020 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Enterprise Value of -$357.9 million in Q1 2026, up 9.15% quarter-over-quarter from -$394.0 million in Q4 2025, and up 24.66% on a YoY basis from -$287.1 million in Q1 2025.
MoonLake Immunotherapeutics (MLTX) Enterprise Value (2020 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$357.9 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 24.66% year-over-year to -$357.9 million; the TTM figure through Mar 2026 stood at -$357.9 million (up 24.66% YoY), while the FY2025 annual figure was -$394.0 million, up 10.76% from the prior year.
- Enterprise Value was -$357.9 million for Q1 2026 at MoonLake Immunotherapeutics, up from -$394.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $31.0 million in Q2 2022 to a low of -$537.2 million in Q1 2024.
- Historically, Enterprise Value has averaged -$331.9 million across 5 years, with a median of -$420.9 million in 2025.
- Biggest YoY gain for Enterprise Value was 2928.04% in 2022; the steepest drop was 8533.99% in 2022.
- A 5-year view of Enterprise Value shows it stood at -$52.2 million in 2022, then plunged by 843.98% to -$493.2 million in 2023, then gained by 10.49% to -$441.5 million in 2024, then advanced by 10.76% to -$394.0 million in 2025, then gained by 9.15% to -$357.9 million in 2026.
- The last three Enterprise Value figures came in at -$357.9 million (Q1 2026), -$394.0 million (Q4 2025), and -$378.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - | -357.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -357.92 Mn |
| Dec 31, 2025 | -393.97 Mn |
| Sep 30, 2025 | -378.19 Mn |
| Jun 30, 2025 | -420.87 Mn |
| Mar 31, 2025 | -475.07 Mn |
| Dec 31, 2024 | -441.46 Mn |
| Sep 30, 2024 | -486.62 Mn |
| Jun 30, 2024 | -510.43 Mn |
| Mar 31, 2024 | -537.22 Mn |
| Dec 31, 2023 | -493.19 Mn |
| Sep 30, 2023 | -431.27 Mn |
| Jun 30, 2023 | -492.47 Mn |
| Mar 31, 2023 | -45.92 Mn |
| Dec 31, 2022 | -52.25 Mn |
| Sep 30, 2022 | -56.22 Mn |
| Jun 30, 2022 | 31.04 Mn |
| Mar 31, 2022 | -101.02 Mn |
| Dec 31, 2021 | -8.04 Mn |
| Sep 30, 2021 | -1.03 Mn |
| Jun 30, 2021 | -1.10 Mn |